Calgary, Alberta, June 1, 2023: – Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) is pleased to announce a non-brokered private placement of up to 10 Million Units priced at $0.12 each, closing in tranches. Each Unit consists
Latest news and articles!
Calgary, Alberta, May 2, 2023 – Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) is pleased to announce it has engaged Chris McNorgan, PhD, to drive a license agreement of NCP-01 with a company
Calgary, Alberta, March 29, 2023 – Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) is pleased to announce it has engaged Montreal’s RobboDesign to revise and search engine optimize its website, to engage with
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Calgary, Alberta, March 21, 2023 – Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) is pleased to announce that it
Calgary, Alberta, March 8, 2023: – Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) announces it is repricing its offering of 14 Million Common Share Units to $0.20 each. Each Unit consists of one common share in the
Calgary, Alberta, March 7, 2023: – Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) (“HEM” or the “Company”) is pleased to announce it is selling up to 500 five-year 6% unsecured convertible debentures (“CD”) at USD $35,000 each.
Calgary, Alberta, February 1, 2023: – Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0) is pleased to announce a non-brokered private placement of up to 14 Million Units priced at $0.24 each, closing in tranches. Each Unit consists
Calgary, Alberta, January 31, 2023: – Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) (FSE:2VF0) is pleased to announce it is plugged into the largest network of family offices in the United States
Calgary, Alberta, January 30, 2023: – Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) (FSE:2VF0) is pleased to announce its Trademark, Your Fountan of Youth, was granted protection in Switzerland by its Trademark
Calgary, Alberta, January 26, 2023: – Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) (FSE:2VF0) is pleased to announce the Japan Patent Office issued Kwalata Trading Limited, a wholly owned subsidiary of Hemostemix